← All trials
NCT02209974
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2004
- Primary completion
- Nov 1, 2009
- Completion date
- Nov 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 23
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Hospital Son LlatzerLead sponsor
- Hospital Son LlatzerOverall official - principal investigator
- Hospital Son LlatzerReponsible party - principal investigator
- Hospital Son EspasesStudy chair
- Fundació Investigació de les Illes BalearsStudy chair
- Sociedad Española de Neumología y Cirugía TorácicaCollaborator
- Hospital Son EspasesCollaborator
- Spanish Research Center for Respiratory DiseasesCollaborator
- University of BarcelonaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.